Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00009750 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: monoclonal antibody m170
DRUG: cyclosporine
DRUG: paclitaxel
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: indium In 111 monoclonal antibody m170
RADIATION: yttrium Y 90 monoclonal antibody m170

Sponsor

University of California, Davis